EGFR and non-small cell lung carcinoma: Here, data from TKI-treated NSCLC cell lines were preferentially focused on since the concept of DTP was mostly studied in vitro in epidermal growth factor receptor (EGFR)-mutant NSCLC (Figure 1C).